Wolverine Trading, LLC Ampio Pharmaceuticals, Inc. Transaction History

Wolverine Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$1.56 - $1.98 $30,683 - $38,944	-19,669 Reduced 48.0%	21,308 $36,000
Q4 2020 Feb 12, 2021	SELL	$0.75 - $2.76 $34 - $126	-46 Reduced 0.11%	40,977 $61,000
Q3 2020 Nov 13, 2020	SELL	$0.61 - $1.17 $4,540 - $8,708	-7,443 Reduced 15.36%	41,023 $39,000
Q2 2020 Aug 13, 2020	BUY	$0.47 - $0.72 $2,910 - $4,458	6,193 Added 14.65%	48,466 $32,000
Q1 2020 May 11, 2020	BUY	$0.36 - $0.74 $8,073 - $16,595	22,426 Added 112.99%	42,273 $18,000
Q3 2019 Nov 14, 2019	BUY	$0.38 - $0.52 $1,924 - $2,633	5,065 Added 34.26%	19,847 $10,000
Q2 2019 Aug 20, 2019	BUY	$0.39 - $0.7 $5,764 - $10,347	14,782 New	14,782 $6,000
Q3 2018 Nov 14, 2018	SELL	$0.44 - $3.02 $13,030 - $89,437	-29,615 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.16 - $3.48 $38,063 - $61,324	17,622 Added 146.94%	29,615 $101,000
Q3 2017 Nov 15, 2017	BUY	$0.38 - $0.66 $4,557 - $7,915	11,993	11,993 $7,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.